V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010745 | 280006577 | 0 | 77.7 | Palliative (P) | 2014-11-25 | 2015-05-30 | IFOSFAMIDE + VINCRISTINE | N | null | 280030712 | BCG |
| 280010746 | 280006580 | 1.88 | 83.8 | null | 2017-03-14 | 2017-07-17 | OCTREOTIDE | 02 | null | 280030717 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010747 | 280006582 | null | null | Palliative (P) | 2013-11-16 | 2013-11-18 | Capecitabine + Oxaliplatin 21day | 01 | N | 280030724 | CARBOPLATIN + PEMETREXED |
| 280010748 | 280006584 | 1.55 | 52.4 | Palliative (P) | 2017-05-29 | 2017-05-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 280030724 | NIVOLUMAB |
| 280010749 | 280006589 | 1.78 | 73 | Palliative (P) | 2019-02-18 | 2019-02-22 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 280030742 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010750 | 280006589 | 1.77 | 72 | Neo-adjuvant (N) | 2017-05-03 | 2017-05-03 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 280030742 | VIDE |
| 280010751 | 280006593 | 1.59 | 62.5 | Neo-adjuvant (N) | 2015-07-23 | 2015-08-14 | Enzalutamide | N | N | 280030769 | DABRAFENIB + TRAMETINIB |
| 280010752 | 280006595 | 1.7 | 68.9 | null | 2016-11-09 | 2016-11-11 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | 280030774 | CARBOPLATIN + CETUXIMAB + FU |
| 280010753 | 280006598 | null | 79.75 | Palliative (P) | null | 2016-04-10 | CARBOPLATIN + CETUXIMAB | N | N | 280030785 | CARBOPLATIN + CETUXIMAB |
| 280010754 | 280006600 | 1.7 | 88.35 | Palliative (P) | 2017-08-13 | 2017-08-17 | OCTREOTIDE | 02 | N | 280030786 | CMV |
| 280010755 | 280006600 | null | 87.1 | Palliative (P) | 2017-06-07 | 2017-06-27 | Sunitinib | 02 | N | 280030786 | CAPECITABINE + CISPLATIN |
| 280010756 | 280006601 | 1.69 | 70 | Palliative (P) | 2019-01-24 | 2019-01-25 | Cyclophosphamide High Dose | N | N | 280030791 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280010757 | 280006604 | null | null | Palliative (P) | 2015-06-06 | 2016-01-28 | FEC | N | N | 280030812 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010758 | 280009436 | 1.7 | 67 | Palliative (P) | 2016-11-21 | 2016-11-28 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280030815 | IVADO |
| 280010759 | 280006609 | 1.79 | 68.4 | Palliative (P) | 2016-01-01 | 2016-01-13 | PEMBROLIZUMAB | 02 | N | 280030816 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010760 | 280006612 | null | 115 | Palliative (P) | 2018-08-14 | 2018-08-17 | IFOSFAMIDE + VINCRISTINE | null | null | 280030828 | DACTINOMYCIN + VINCRISTINE |
| 280010761 | 280010800 | 1.72 | 11.1 | Palliative (P) | null | 2014-06-03 | VIDE | N | N | 280013299 | CARBO + FLUOROURACIL |
| 280010762 | 280009442 | 1.65 | 63 | Palliative (P) | 2019-05-14 | 2019-05-14 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 280016663 | NIVOLUMAB |
| 280010763 | 280006619 | 1.67 | 109.8 | Palliative (P) | 2017-03-08 | 2017-03-08 | Cyclophosphamide PO +Vinorelbine IV | N | null | 280017961 | KESTREL TRIAL |
| 280010764 | 280006620 | null | 98.55 | Curative (C) | null | 2015-04-19 | ETOPOSIDE | null | null | 280018042 | CISPLATIN + FLUOROURACIL + RT |
| 280010765 | 280009446 | 1.75 | 66.4 | Palliative (P) | 2013-08-19 | 2014-09-20 | Bevacizumab 7.5mg/kg | 2 | N | 280018104 | CISPLATIN + DOCETAXEL + FLUOROURACIL + RT |
| 280010766 | 280011472 | 1.8 | 73.5 | Palliative (P) | 2015-07-30 | 2015-08-05 | PEMBROLIZUMAB | N | N | 280018423 | DOCETAXEL |
| 280010767 | 280011472 | 1.94 | 79 | Palliative (P) | 2017-08-28 | 2017-09-17 | Cisplatin + Fluorouracil + RT 5day | N | N | 280018423 | GEMCARBO |
| 280010768 | 280006625 | 1.65 | 73 | Adjuvant (A) | 2015-04-27 | 2015-06-12 | Dacarbazine | N | N | 280018531 | IVADO |
| 280010769 | 280006627 | 1.67 | 68.4 | null | 2016-02-14 | 2016-03-04 | Everolimus 10mg | null | N | 280018844 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280010770 | 280009448 | null | null | Palliative (P) | 2016-09-10 | 2017-03-11 | ECX | 01 | N | 280019073 | METHOTREXATE HIGH DOSE |
| 280010771 | 280006632 | 0 | 79.5 | Palliative (P) | 2017-05-29 | 2017-08-22 | Dactinomycin + Vincristine | N | N | 280019109 | ALEMTUZUMAB |
| 280010772 | 280009450 | null | null | Curative (C) | 2017-06-20 | 2017-06-20 | IVADo | 02 | N | 280019202 | CASPS TRIAL |
| 280010773 | 280006635 | 0 | 70 | Disease modification (D) | 2018-09-15 | 2018-09-15 | OCTREOTIDE | 02 | N | 280019278 | VIDE |
| 280010774 | 280009452 | 1.62 | 51.3 | Palliative (P) | 2016-07-25 | 2016-07-25 | FLUOROURACIL + MITOMYCIN | 02 | null | 280019281 | DOCETAXEL |
| 280010775 | 280006638 | 1.75 | 52 | Palliative (P) | 2016-02-03 | 2017-01-23 | ECX | N | N | 280019450 | BCG |
| 280010776 | 280006641 | 1.7 | 66.3 | Palliative (P) | 2012-11-23 | 2014-03-30 | DACTINOMYCIN + CYCLO + VINCRISTINE | 02 | N | 280019477 | PERTUZUMAB + TRASTUZUMAB |
| 280010777 | 280006648 | null | 89.2 | Palliative (P) | 2014-02-10 | 2014-02-24 | VINCRISTINE | N | N | 280019933 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280010778 | 280006653 | 0 | 74.3 | Palliative (P) | null | 2015-11-03 | ECX | N | N | 280020096 | GEFITINIB |
| 280010779 | 280009457 | 1.6 | 82.8 | Neo-adjuvant (N) | null | 2019-07-29 | Y-90 | 02 | null | 280020346 | CAPECITABINE |
| 280010780 | 280006660 | 1.77 | 119 | Palliative (P) | 2016-05-18 | 2016-06-15 | NIVOLUMAB | Y | N | 280020449 | ABIRATERONE |
| 280010781 | 280006663 | 1.55 | 99.9 | Palliative (P) | 2014-01-28 | 2014-01-28 | STS Rhabdo VIT0910 Vinc Irinotecan | N | N | 280020492 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280010782 | 280006665 | 1.79 | null | null | 2016-08-01 | 2016-08-07 | BCG Intravesical | 02 | N | 280020538 | CISPLATIN + FLUOROURACIL + RT |
| 280010783 | 280009461 | 1.54 | 43.5 | Curative (C) | 2015-07-01 | 2015-07-13 | PEMBROLIZUMAB | 02 | N | 280020664 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280010784 | 280006668 | 1.7 | null | Palliative (P) | 2018-06-20 | 2018-06-20 | Cisplatin + Doxorubicin | N | null | 280020669 | BORTEZOMIB |
| 280010785 | 280006674 | null | 61 | Palliative (P) | 2014-04-13 | 2014-05-27 | CARBOPLATIN + FLUOROURACIL | N | N | 280020683 | PAZOPANIB |
| 280010786 | 280010815 | 1.67 | null | Palliative (P) | 2019-02-03 | 2019-02-04 | ECX | N | N | 280020957 | BUSULFAN + MELPHALAN |
| 280010787 | 280006677 | 1.62 | null | Palliative (P) | null | 2015-10-18 | BCG Intravesical | null | null | 280021219 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280010788 | 280006680 | 1.76 | null | Palliative (P) | 2018-02-08 | 2018-03-01 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 01 | N | 280021328 | IRINOTECAN |
| 280010789 | 280009468 | 1.62 | 85 | Palliative (P) | 2013-05-11 | 2016-03-30 | CAPECITABINE + OXALIPLATIN | N | N | 280021363 | MITOMYCIN INTRAVESICULAR |
| 280010790 | 280006684 | 1.73 | 11.1 | Palliative (P) | 2019-01-14 | 2019-01-14 | IVADo | null | null | 280021411 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280010791 | 280006686 | 1.65 | 72.5 | Palliative (P) | 2016-11-07 | 2016-12-02 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | 280021971 | ETOPOSIDE |
| 280010792 | 280006689 | 1.74 | null | Curative (C) | 2017-05-18 | 2017-05-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 280022198 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010793 | 280006691 | null | 94.1 | Palliative (P) | 2015-07-02 | 2015-07-29 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | N | N | 280022483 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010794 | 280009473 | 1.7 | 53.8 | Palliative (P) | 2016-02-10 | 2016-02-11 | BUSULFAN + MELPHALAN | N | N | 280022533 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |